Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

• Sarah A. Westergaard, MD,
• Mary Jo Lechowicz, MD,
• Maggie Harrington, NP-C,
• Justin Elsey, BS,
• Jack L. Arbiser, MD, PhD,
• Mohammad K. Khan, MD

Affiliations

Sarah A. Westergaard, MD

Department of Radiation Therapy, Emory University School of Medicine, Atlanta, Georgia

Mary Jo Lechowicz, MD

Department of Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia

Maggie Harrington, NP-C

Department of Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia

Justin Elsey, BS

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia

Jack L. Arbiser, MD, PhD

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia; Veterans Affairs Medical Center, Decatur, Georgia; Correspondence to: Jack L. Arbiser, MD, PhD, Department of Dermatology, Emory University School of Medicine, WMB 5309, 101 Woodruff Circle, Atlanta, GA 30322.

Mohammad K. Khan, MD

Department of Radiation Therapy, Emory University School of Medicine, Atlanta, Georgia